Zydus Worldwide DMCC, a wholly-owned subsidiary, and Daewoong Pharmaceutical Co Ltd have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for depot suspension in six dosage strengths for the US market, Zydus Lifesciences said in a regulatory filing.
Zydus And Daewoong Pharmaceutical Announces Exclusive Licensing Agreement To Co-develop & Commercialize Leuprolide Acetate freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.
Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase Biocon Biologics Ltd’s dermatology and ..